Key facts
- Notable investors include RA Capital Management.
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Radence
Funding rounds
1 roundsAbout Radence
Developer of a proactive health assurance platform intended to guide early decisions for optimal health. The company offers a full-service support team, combined with evidence-based personalized diagnostic capabilities, enabling clinical partners more tools to stay ahead and deliver even greater impact for their patients.
- Industry
- Decision/Risk Analysis
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Employees
- 9
- Website
- radence.com/
- Ownership
- Privately Held (backing)
Radence doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Radence shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Radence in its N-PORT filings yet. We sweep new filings monthly.